Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent platinum-sensitive ovarian cancer

Authors :: C. Pozzo
Domenica Lorusso
Valerio Gallotta
Giovanni Scambia
Antonia Carla Testa
Giuseppe D'Agostino
A. Naldini
Gabriella Ferrandina
Ida Paris
Manuela Ludovisi
Source :: Journal of Clinical Oncology. 22:5078-5078
Publication Year :: 2004
Publisher :: American Society of Clinical Oncology (ASCO), 2004.
Abstract: 5078 Background: We conducted a phase II study in order to evaluate the efficacy and safety of the combination of OXA and DTX in recurrent platinum-sensitive ovarian cancer patients. Methods: Patie...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
endocrine system diseases
business.industry
Phases of clinical research
medicine.disease
female genital diseases and pregnancy complications
Oxaliplatin
Docetaxel
Internal medicine
medicine
Platinum sensitive
Ovarian cancer
business
medicine.drug

Tools